Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
A SPAC I Acquisition A | ASCA | 28. mar 2024 | 9.43 | +8.14 |
A SPAC I Acquisition Unit | ASCAU | 28. mar 2024 | 9.67 | -9.79 |
A SPAC II Acquisition | ASCB | 28. mar 2024 | 11.14 | -0.98 |
A-Mark Precious Metals | AMRK | 28. mar 2024 | 30.69 | +2.13 |
a.k.a Brands | AKA | 28. mar 2024 | 9.94 | +1.53 |
A.O Smith | AOS | 28. mar 2024 | 89.46 | +0.69 |
A10 Networks | ATEN | 28. mar 2024 | 13.69 | +0.07 |
AAA - A Rated Corporate Bond Ishares | QLTA | 28. mar 2024 | 47.48 | -0.13 |
Aadi Bioscience | AADI | 28. mar 2024 | 2.34 | -1.27 |
AAON | AAON | 28. mar 2024 | 88.10 | +1.65 |
AAR | AIR | 28. mar 2024 | 59.87 | -0.52 |
Abacus Life | ABL | 28. mar 2024 | 12.18 | +4.46 |
Abbott Laboratories | ABT | 28. mar 2024 | 113.66 | +0.16 |
AbbVie | ABBV | 28. mar 2024 | 182.10 | +0.97 |
AbCellera Biologics | ABCL | 28. mar 2024 | 4.53 | +0.89 |
Abeona Therapeutics | ABEO | 28. mar 2024 | 7.25 | -1.23 |
Abercrombie & Fitch | ANF | 28. mar 2024 | 125.33 | +3.27 |
Aberdeen Asia-Pacificome Fund | FAX | 28. mar 2024 | 2.80 | +1.08 |
Aberdeen Australia Equity Fund | IAF | 28. mar 2024 | 4.26 | +0.47 |
Aberdeen Emerging Markets Fund | AEF | 28. mar 2024 | 5.05 | +0.20 |
Aberdeen Global Fund | FCO | 28. mar 2024 | 5.43 | +0.56 |
Aberdeen Global Infrastructure | ASGI | 28. mar 2024 | 17.75 | 0.00 |
Aberdeen Income Credit Strategies Fund | ACP | 28. mar 2024 | 6.78 | +0.44 |
Aberdeen Income Credit Strategies Pref | ACP-A | 28. mar 2024 | 24.98 | 0.00 |
Aberdeen Japan Equity Fund | JEQ | 28. mar 2024 | 6.23 | -0.32 |
Abits Group | ABTS | 28. mar 2024 | 0.69 | -12.81 |
Abivax SA - American Depositary Shares | ABVX | 28. mar 2024 | 14.30 | -3.31 |
Able View Global | ABLV | 28. mar 2024 | 2.47 | +10.27 |
ABM Industries | ABM | 28. mar 2024 | 44.62 | +0.47 |
Abrdn Global Dynamic Dividend Fund | AGD | 28. mar 2024 | 9.71 | +0.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.